Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of Chronic Philadelphia Negative Myeloproliferative Neoplasms

NCT02862366 is registered in ClinicalTrials.gov with Lille Catholic University as lead sponsor.

NCT NCT02862366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02862366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of Chronic Philadelphia Negative Myeloproliferative Neoplasms
Lead sponsor
Lille Catholic University
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
January 25, 2016
Enrollment
128 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

myeloproliferative neoplasm